Compare Nebius Group NV (NBIS) vs Nuvalent Inc (NUVL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nebius Group NV vs Nuvalent Inc — how do they compare? Nebius Group NV trades at $219.49 (market cap $46.37B), while Nuvalent Inc trades at $123.96 (market cap $9.81B). The key difference: Nebius Group NV is far larger — about 4.7× Nuvalent Inc's market cap, and Nuvalent Inc is trading nearer its 52-week high, Nebius Group NV nearer its low. Which is the better fit depends on your goals.
| NBIS | NUVL | |
|---|---|---|
Market Cap | $46.37B | $9.81B |
Sector | Technology | Technology |
52-Week High | $286.69 | $123.96 |
52-Week Low | $50.40 | $72.16 |
Enterprise Value | $46.56B | $8.52B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nebius Group NV
Nebius Group N.V. is a technology company specializing in AI, machine learning, and cloud computing solutions. The company provides a range of enterprise-level cloud services, including large-scale data processing, advanced analytics, and AI model development and deployment. Nebius Group focuses on serving businesses that require high-performance, scalable, and secure infrastructure to handle complex computational tasks and accelerate their digital transformation.
Read more on NBIS →About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →
